NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









3X4 Genetics

3X4 Genetics

Private
Bellevue, WashingtonHealthcare & Life Scienceshttps://3x4genetics.com/

Last Round

Series A

Dec 12, 2019

Total Funding Raised

$2.5M

Company Overview

3X4 Genetics is a health technology company that provides a genetics-based health assessment platform using a DNA test to offer personalized wellness insights.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

genetic testingnutrigenomicsnutrigeneticspersonalized nutritionDNA analysispractitioner platformfunctional medicinegenetic reportpathway analysisintegrative medicineprecision medicineB2B2C healthcareAI health analyticsbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

3X4 Genetics Comps

Public and private peers based on sector, stage, and business model.

3X4 Genetics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

3X4 Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 12, 2019
AngelJan 1, 2018

Key People

Founding team and executive leadership

Tony Hsu

Chief Executive Officer

Executive Team

3X4 Genetics Investors

Notable investors and investment history

3X4 Genetics investors
InvestorRounds
Alethea Capital Management, LLCSeries A
HAVAÍCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 42% MoM to 69.7K.

  • Jun 6, 2025

    Grew 15% QoQ, from 33 to 38 employees.

3X4 Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

3X4 Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 3X4 Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range45
Year Founded2018
Last FundingDec 12, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.